Goterra, a Canberra-based insect-agriculture startup once valued at $55 million and described as Australia's most-funded insect farm, has entered voluntary administration.
The company attributed the move to a funding shortfall rather than a product or market failure, underscoring how capital availability — not technology — is reshaping the commercial insect-farming sector.
The case adds to a string of high-profile setbacks for industrial-scale insect protein and raises broader questions about the structural model needed to make commercial insect farming durably investable.